Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Edan

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Brain : a Journal of Neurology|March 1, 2011
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibilityNicolas Couturier, Florence Bucciarelli, Ramil N Nurtdinov, et al.
Frontiers in Immunology|January 23, 2025
Blood immunophenotyping of multiple sclerosis patients at diagnosis identifies a classical monocyte subset associated to disease evolutionStéphane Rodriguez, Laura Couloume, Juliette Ferrant, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 23, 2020
Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple SclerosisSophie Mathais, Xavier Moisset, Bruno Pereira, et al.
Multiple Sclerosis and Related Disorders|April 3, 2022
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questionsPaola Zaratin, Patrick Vermersch, Maria Pia Amato, et al.
Neurogenetics|November 5, 2003
Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative studyMargaret A Pericak-Vance, Jackie B Rimmler, Jonathan L Haines, et al.
The Lancet. Neurology|July 23, 2011
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoringLudwig Kappos, David Bates, Gilles Edan, et al.
JAMA|March 10, 2025
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical TrialEric Thouvenot, David Laplaud, Christine Lebrun-Frenay, et al.
European Radiology|April 4, 2025
Evaluation of a deep learning segmentation tool to help detect spinal cord lesions from combined T2 and STIR acquisitions in people with multiple sclerosisBaptiste Lodé, Burhan Rashid Hussein, Cédric Meurée, et al.
Journal of Neurology|April 25, 2019
Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesionsXavier Ayrignac, Valérie Rigau, Benoit Lhermitte, et al.
Multiple Sclerosis and Related Disorders|November 29, 2025
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)-an individual participant data meta-analysisLisa G Schoof, Brit Ellen Rød, Sahla El Mahdaoui, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Brain : a Journal of Neurology|March 1, 2011
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibilityNicolas Couturier, Florence Bucciarelli, Ramil N Nurtdinov, et al.
Frontiers in Immunology|January 23, 2025
Blood immunophenotyping of multiple sclerosis patients at diagnosis identifies a classical monocyte subset associated to disease evolutionStéphane Rodriguez, Laura Couloume, Juliette Ferrant, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 23, 2020
Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple SclerosisSophie Mathais, Xavier Moisset, Bruno Pereira, et al.
Multiple Sclerosis and Related Disorders|April 3, 2022
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questionsPaola Zaratin, Patrick Vermersch, Maria Pia Amato, et al.
Neurogenetics|November 5, 2003
Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative studyMargaret A Pericak-Vance, Jackie B Rimmler, Jonathan L Haines, et al.
The Lancet. Neurology|July 23, 2011
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoringLudwig Kappos, David Bates, Gilles Edan, et al.
JAMA|March 10, 2025
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical TrialEric Thouvenot, David Laplaud, Christine Lebrun-Frenay, et al.
European Radiology|April 4, 2025
Evaluation of a deep learning segmentation tool to help detect spinal cord lesions from combined T2 and STIR acquisitions in people with multiple sclerosisBaptiste Lodé, Burhan Rashid Hussein, Cédric Meurée, et al.
Journal of Neurology|April 25, 2019
Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesionsXavier Ayrignac, Valérie Rigau, Benoit Lhermitte, et al.
Multiple Sclerosis and Related Disorders|November 29, 2025
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)-an individual participant data meta-analysisLisa G Schoof, Brit Ellen Rød, Sahla El Mahdaoui, et al.
Pageof 15